Previously, I discussed common challenges faced by Sponsors dissatisfied with their access program vendor’s service. You can read the full article by clicking here.
If any of these issues resonate with you, know that you’re not alone, and there are alternative solutions available. Many Sponsors opt to transition their access programs from their initial vendors. Below, I’ve highlighted five crucial considerations to guide you through this decision.
The initial step is to acknowledge the problem, followed by identifying its nature. What are the primary challenges for your team, your sites, and other key stakeholders? What are your expectations, and how is your current vendor not meeting them? Clearly identifying these issues will guide you in selecting the right vendor to take over.
It is absolutely normal to switch vendors, and many companies do. Programs evolve and companies and needs change. The best solution for yesterday isn’t always the best solution today. Recognizing that a change can be made is the first step to improving treatment access for your patients and optimizing your company operations.
Select a vendor experienced in access program transition management, such as WEP, who can expertly guide the process. They should be able to design a comprehensive and customized transition plan, clearly outline roles and responsibilities, identify KPIs, ensure open communication channels, and prioritize a seamless transition without disrupting patient treatment access.
Effective site management and support are crucial throughout this process. It's essential that all treating physicians are informed about the transition and understand their roles. Given that sites will have varying experience levels with expanded access, a one-size-fits-all approach won't work. Support must be customized to meet the specific needs of each site.
Conclusion
At WEP, we’ve successfully guided numerous Sponsors in transitioning their access programs from the initial vendor to our services. Our expertise ensures a seamless transition process from start to finish, enabling Sponsor teams to redirect their internal resources toward clinical trials and commercialization efforts.
If you’re interested in discussing how we can assist with your program transition, please feel free to reach out.
